Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00753935 · ClinicalTrials.gov registry record · Early Phase 1

Aspirin Resistance in Coronary Artery Disease

A Early Phase 1 study of Coronary Artery Disease, sponsored by Vanderbilt University.

Completed
Registry status
Early Phase 1
Development phase
92
Enrollment target
1
Study location

NCT00753935 is a Early Phase 1 study of Coronary Artery Disease that has completed, run by Vanderbilt University. The registered enrollment target is 92 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00753935, a Early Phase 1 study of Coronary Artery Disease, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
Early Phase 1
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate possible mechanisms of aspirin resistance at a molecular level in aspirin-treated patients with coronary artery disease. We hypothesize that certain patient characteristics associate with aspirin resistance. In addition, we will compare the effects of enteric-coated aspirin and chewable aspirin.

Conditions Studied

Coronary Artery Disease

Interventions

  • DRUG enteric-coated aspirin
  • DRUG Chewable aspirin

Study Locations (1)

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2006-06
Est. Completion 2014-03
Phase Early Phase 1

Sponsor

Vanderbilt University

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00753935

The ClinicalTrials.gov registry entry for NCT00753935 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which enteric-coated aspirin is the first listed.

NCT00753935 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00753935 about?

NCT00753935 is a clinical study titled "Aspirin Resistance in Coronary Artery Disease". The purpose of this study is to evaluate possible mechanisms of aspirin resistance at a molecular level in aspirin-treated patients with coronary artery disease. We hypothesize that certain patient characteristics associate with aspirin resistance. In addition, we will compare the effects of enteric...

What is the current status of trial NCT00753935?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 92 participants. The study started on 2006-06. Estimated completion is 2014-03.

What conditions does trial NCT00753935 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT00753935?

The interventions under investigation include: enteric-coated aspirin (DRUG), Chewable aspirin (DRUG).

Who is sponsoring clinical trial NCT00753935?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00753935 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Tennessee

All trials with a study site in Tennessee

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.